Oral Minoxidil for Alopecia in Systemic Sclerosis, Dermatomyositis, Mixed Connective Tissue Disease, and Undifferentiated Connective Tissue Disease: A Retrospective Cohort Study on Cardiovascular Risk
Published: 13 March 2026| Version 1 | DOI: 10.17632/c88dvgsccz.1
Contributors:
Isabella Zappi, Archie Spindler, Derek Maas, Devyn Zaminski, Kelley Sharp, Nikita Lakdawala, Vikash Oza, Seth Orlow, Jerry Shapiro, Avrom Caplan, Alisa Femia, Kristen Lo Sicco, Daniel MazoriDescription
Overall patient demographics, connective tissue disease characteristics, oral minoxidil characteristics, and cardiovascular risk factors and outcomes from retrospective study examining cardiovascular risk of oral minoxidil for alopecia in systemic sclerosis, dermatomyositis, mixed connective tissue disease, and undifferentiated connective tissue disease.
Files
Institutions
- NYU Langone HealthNew York, New York
- University of Rochester Medical CenterNew York, Rochester
- University of ConnecticutConnecticut, Storrs
Categories
Minoxidil, Connective Tissue, Cardiovascular Disease, Connective Tissue Disorder, Dermatomyositis, Alopecia, Systemic Sclerosis, Mixed Connective Tissue Disease, Pericardial Effusion